{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:36:23Z","timestamp":1777394183104,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2015,8,3]]},"DOI":"10.3233\/jad-150289","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T12:33:28Z","timestamp":1438691608000},"page":"741-750","source":"Crossref","is-referenced-by-count":2,"title":["No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"47","author":[{"given":"Justin Tao Wen","family":"Chiam","sequence":"first","affiliation":[{"name":"Guy\u2019s, King\u2019s and St Thomas School of Medical Education, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Lunnon","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Biomedical Science, University of Exeter, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Voyle","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"MRC Social, Genetic and Developmental Psychiatry Centre, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petroula","family":"Proitsi","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health and Biomedical Research, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Coppola","sequence":"additional","affiliation":[{"name":"Department of Neurology, Programme in Neurogenetics, David Geffen School of Medicine, University of California at Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Geschwind","sequence":"additional","affiliation":[{"name":"Department of Neurology, Programme in Neurogenetics, David Geffen School of Medicine, University of California at Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Nelson","sequence":"additional","affiliation":[{"name":"SomaLogic, Boulder, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Johnston","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health and Biomedical Research, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilkka","family":"Soininen","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"K\u0142oszewska","sequence":"additional","affiliation":[{"name":"Medical University of Lodz, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Mecocci","sequence":"additional","affiliation":[{"name":"Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Tsolaki","sequence":"additional","affiliation":[{"name":"3rd Department of Neurology, \u201cG. Papanicolaou\u201d Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[{"name":"INSERM U 558, University of Toulouse, Toulouse, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Hodges","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health and Biomedical Research, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lovestone","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"Department of Psychiatry, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Newhouse","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health and Biomedical Research, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard James Butler","family":"Dobson","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health and Biomedical Research, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven John","family":"Kiddle","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"MRC Social, Genetic and Developmental Psychiatry Centre, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Sattlecker","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health and Biomedical Research, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150289_ref1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease.b","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"10.3233\/JAD-150289_ref2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/157488408784293723","article-title":"Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: A review of recent literature","volume":"3","author":"Frankfort","year":"2008","journal-title":"Curr Clin Pharmacol"},{"key":"10.3233\/JAD-150289_ref3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-150289_ref4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jalz.2012.05.2116","article-title":"Development of biomarkers to chart all Alzheimer\u2019s disease stages: The royal road to cutting the therapeutic Gordian Knot","volume":"8","author":"Hampel","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150289_ref5","first-page":"15","article-title":"Alzheimer\u2019s diseasebiomarker discovery in symptomatic and asymptomatic patients:Experimental approaches and future clinical applications","volume":"45","author":"Ho","year":"2010","journal-title":"ExpGerontol"},{"key":"10.3233\/JAD-150289_ref6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150289_ref7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-2010-101518","article-title":"A gene expression pattern in blood for the early detection of Alzheimer\u2019s disease","volume":"23","author":"Booij","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150289_ref8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jalz.2009.07.001","article-title":"Toward an Alzheimer\u2019s disease diagnosis via high-resolution blood gene expression","volume":"6","author":"Fehlbaum-Beurdeley","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150289_ref9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-2012-111592","article-title":"Mitochondrial dysfunction and immune activation are detectable in early Alzheimer\u2019s disease blood","volume":"30","author":"Lunnon","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150289_ref10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat Med"},{"key":"10.3233\/JAD-150289_ref11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","article-title":"Blood-based protein biomarkers for diagnosis of Alzheimer disease","volume":"69","author":"Doecke","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150289_ref12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology","volume":"10","author":"Sattlecker","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150289_ref13","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1002\/elps.201200360","article-title":"Use of proteomic methods in the analysis of human body fluids in Alzheimer research","volume":"33","author":"Zurbig","year":"2012","journal-title":"Electrophoresis"},{"key":"10.3233\/JAD-150289_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.007","article-title":"Blood and plasma-based proteomic biomarker research in Alzheimer\u2019s disease","volume":"101-102","author":"Lista","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-150289_ref15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","article-title":"Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: A systematic review and replication study","volume":"38","author":"Kiddle","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150289_ref16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-140816","article-title":"Are blood-based protein biomarkers for Alzheimer\u2019s disease also involved in other brain disorders? A systematic review","volume":"43","author":"Chiam","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150289_ref17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-121963","article-title":"Characteristic transformation of blood transcriptome in Alzheimer\u2019s disease","volume":"35","author":"Han","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150289_ref18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150289_ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WAD.0b013e318214b7d0","article-title":"Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease","volume":"26","author":"Lauterbach","year":"2012","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-150289_ref20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0269881110387547","article-title":"Clinicalpractice with anti-dementia drugs: A revised (second) consensusstatement from the British Association for Psychopharmacology","volume":"25","author":"O\u2019Brien","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.3233\/JAD-150289_ref21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00002826-200405000-00011","article-title":"Acetylcholinesterase and its inhibition in Alzheimer disease","volume":"27","author":"Lane","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.3233\/JAD-150289_ref22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2013.09.050","article-title":"Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection","volume":"70","author":"Singh","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.3233\/JAD-150289_ref23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jneuroim.2003.11.003","article-title":"Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines","volume":"148","author":"Reale","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-150289_ref24","first-page":"359","article-title":"Biomarkers for disease modification trials\u2013the innovative medicines initiative and AddNeuroMed","volume":"11","author":"Lovestone","year":"2007","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-150289_ref25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.2009.05064.x","article-title":"AddNeuroMed\u2013the European collaboration for the discovery of novel biomarkers for Alzheimer\u2019s disease","volume":"1180","author":"Lovestone","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-150289_ref26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12603-009-0033-x","article-title":"Biomarkers for Alzheimer\u2019s disease trials\u2013biomarkers for what? A discussion paper","volume":"13","author":"Lovestone","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-150289_ref27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-150289_ref28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-150289_ref29","first-page":"661","article-title":"GlobalDeterioration Scale (GDS)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.3233\/JAD-150289_ref30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-150289_ref31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2196\/medinform.3339","article-title":"CohortExplorer: A generic application programming interface (API) for entity attribute value database schemas.e","volume":"2","author":"Dixit","year":"2014","journal-title":"JMIR Med Inform"},{"key":"10.3233\/JAD-150289_ref32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"lumi: A pipeline for processingIllumina microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"key":"10.3233\/JAD-150289_ref33","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1093\/nar\/gkn234","article-title":"Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology","volume":"36","author":"Ding","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/JAD-150289_ref34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1752-0509-6-63","article-title":"Network methods for describing sample relationships in genomic datasets: Application to Huntington\u2019s disease.63-0509-","volume":"6","author":"Oldham","year":"2012","journal-title":"BMC Syst Biol"},{"key":"10.3233\/JAD-150289_ref35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.3233\/JAD-150289_ref36","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150289_ref38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000080966","article-title":"Rivastigmine as amodulator of the neuronal glutamate transporter rEAAC1 mRNAexpression","volume":"19","author":"Andin","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150289_ref39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.eurpsy.2004.09.031","article-title":"Grouping for behoral and psychological symptoms in dementia: Clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium","volume":"20","author":"Robert","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.3233\/JAD-150289_ref41","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1023\/B:NERE.0000029570.57903.74","article-title":"The effect of citalopram on gene expression profile of Alzheimer lymphocytes","volume":"29","author":"Palotas","year":"2004","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-150289_ref42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-2012-121363","article-title":"A blood geneexpression marker of early Alzheimer\u2019s disease","volume":"33","author":"Lunnon","year":"2013","journal-title":"J AlzheimersDis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:37Z","timestamp":1777370557000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,3]]},"references-count":40,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-150289","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,3]]}}}